Falkenburger, B. H. (2018). "Correction to: N-Terminal Fusion Potentiates alpha-Synuclein Secretion." Cell Mol Neurobiol 38 (8): 1555. Falkenburger, B. H. (2018). "N-terminal fusion potentiates alpha-synuclein [...] B ., Nikoubashman O., Pinho J . and Reich A .Classification of patients with embolic stroke of undetermined source into cardioembolic and non-cardioembolic profile subgroups.Eur J Neurol.2022. doi: 10.1111/ene [...] Dafotakis M. , Schubert G. A., Hans F. J. and Jablawi F.Arteriovenous malformations of the filum terminale: clinical characteristics, angioarchitecture, and management of a rare spinal vascular pathology

Publikationen der Klinik für Thorax-, Herz- und Gefäßchirurgie.

Jankowski, J. Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma. Hypertension 70, 412-419, doi:10.1161/HYPERTENSIONAHA.116.08906

pain target NaV1.7 is expressed late during human iPS cell differentiation into sensory neurons as determined in high-resolution imaging." Sensory Physiology. 2024. Van Den Braak N., Dumke C., Broschwitz R

Trautwein, and L. Kuepfer. 2022. Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk. Liver Int 42:640-650. Collin, C.B., T. Gebhardt, M. Golebiewski

13-9. Epub 2011 Apr 22. No abstract available. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Bley C, van der Linden M, Reinert [...] 2010 Meningitis durch Streptococcus pneumoniae Serotyp 19F. Kleinkind nach zweimaliger, nicht termingerechter Pneumokokkenimpfung. Kunze, W., M. van der Linden, T.Klemm, K.Gröger prädiat. prax. 75, 249-254 [...] Witte W, Lütticken R, Klare I. J Clin Microbiol. 1999 May;37(5):1638-41. Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. Spellerberg B, Pohl

gewährt, wobei der Antrag schriftlich oder zu Protokoll bei der Geschäftsstelle bzw. in einem Gerichtstermin gestellt werden kann (vgl. § 117 Abs. 1 ZPO). https://www.justiz.nrw.de/BS/formulare/prozess [...] training-mehr-sicherheit-im-umgang-mit-schwierigen-und-aggressiven-personen/ ) zu verschiedenen Terminen Seminare in ganz Deutschland an, für die man sich mittels eines Anmeldeformulars https://heike-heitmann

generated in bulk culture . PLoS ONE . (2013) 8(5): e65324. Koch CM, Wagner W. Epigenetic Biomarker to Determine Replicative Senescence of Cultured Cells . Methods in Molecular Biology . (2013) 1048: 309-321. [...] . Cytotherapy . (2012) 14(4): 401-411. 2011 Koch C and Wagner W. Epigenetic-Aging-Signature to determine age in different tissues . Aging . (2011) 3: 1-10. Schellenberg A, Lin Q, Schueler H, Koch CM, Joussen

1947-1955 Bayoudh W, Carstesen D, Walter P, Weinberger AWA Author reply: central corneal thickness determination in corneal edema. Graefes Arch Clin Exp Ophthalmol. 2017;255(6): 1253-1254 Kuerten D, Plange N [...] Kuerten D, Johnen S, Harmening N, Souteyrand G, Walter P, Thumann G Central corneal thickness determination in corneal edema using ultrasound pachymetry, a Scheimpflug camera, and anterior segment OCT. [...] 30 (3): 287-294 JAN 2009 [11] VanNasdale DA, Elsner AE, Weber A, Miura M, Haggerty BP. (2009). Determination of foveal location using scanning laser polarimetry. Journal of Vision, 9(3):21, 1-17 Publikationen

Reetz K , Kleiman A, Klein C, Lencer R, Zühlke C, Brockmann K, Rolfs A, Binkofski F. CAG repeats determine brain atrophy in Spinocerebellar Ataxia 17: A VBM Study. PloS One , 2011;6(1):e15125. 2010 Brüggemann [...] Siebner HR, Klein C, Binkofski F. Structural imaging in the presymptomatic stage of genetically determined parkinsonism. Neurobiol Dis , 2010;39(3):402-408. Stanley K, Hagenah J, Brüggemann N, Reetz K [...] Pramstaller PP, Siebner HR, Binkofski F. Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson’s disease. Movement Disorders , 2009;24(1): 99-103. Rief W, Nestoriuc